Risk of Metabolic Complications in Kidney Transplantation After Conversion to mTOR Inhibitor: A Systematic Review and Meta-Analysis
Author:
Affiliation:
1. Department of Medicine; Beth Israel Medical Center; New York NY
2. Transplantation Research Center, Renal Division, Brigham & Women's Hospital, Boston Children's Hospital; Harvard Medical School; Boston MA
Funder
American Heart Association
Publisher
Wiley
Subject
Pharmacology (medical),Transplantation,Immunology and Allergy
Reference55 articles.
1. Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: One-year analysis of a randomized multicenter trial;Guba;Transplantation,2010
2. Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: Concept study;Lebranchu;Am J Transplant,2009
3. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial;Schena;Transplantation,2009
4. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: An open-label, randomised, controlled trial;Budde;Lancet,2011
5. Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: A systematic review of the evidence;Mulay;Transplantation,2006
Cited by 97 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A review of landmark studies on maintenance immunosuppressive regimens in kidney transplantation;Asian Biomedicine;2024-06-01
2. An update review of post‐transplant diabetes mellitus: Concept, risk factors, clinical implications and management;Diabetes, Obesity and Metabolism;2024-04
3. Metabolic Disorders in Liver Transplant Recipients: The State of the Art;Journal of Clinical Medicine;2024-02-09
4. Diabetic Kidney Disease in Post-Kidney Transplant Patients;Journal of Clinical Medicine;2024-01-30
5. Management of new onset dysglycemia in transplant recipients;Metabolic Syndrome;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3